NIH

Envisagenics’ artificial intelligence wows real investors

By GREGORY ZELLER // They’re on a major roll at Envisagenics Inc., a Cold Spring Harbor Laboratory spinoff that’s piling up some hefty research grants. Now based in New York City, the biotech announced this week that it’s been awarded a $1.5 million Small Business Innovation Research Phase II grant from the National Institutes of Health – the second time the NIH has backed the data-crunching startup. The new award is earmarked for the continued…


NIH backs SBU-based biotech’s tuberculosis effort

By GREGORY ZELLER // A Setauket-based pharmaceuticals startup specializing in biomarker analysis has landed a chunky National Institutes of Health research award. Chronus Pharmaceuticals, founded and managed by researchers representing Stony Brook University and an assortment of other prestigious research institutions, announced this week that it has received a $299,172 Phase I Small Business Technology Transfer award from the NIH’s National Institute of Allergy and Infectious Diseases. The award, received in partnership with SBU’s Department…


For SUNY medical schools, difficult choices ahead

By GREGORY ZELLER // With various D.C. follies choking off federal funding, SUNY’s academic medical centers are starting to feel the pinch. And the State University’s teaching hospitals – including Stony Brook University Hospital – may have to roll back certain services to remain solvent, according to a top SUNY officer. As reported this week (subscriber content) by Politico, Ricardo Azziz, SUNY’s chief officer of academic health and hospital affairs, on Nov. 15 told a…


No. 258: Northwell’s big week, Winthrop’s ambitious diabetes study and the Center on Rural Innovation

Welcome, dear readers: To another Wednesday edition of your exclusive Innovate LI newsletter, coming to you on this Ides of November. Before we highlight another busy week in Long Island socioeconomics, a gentle reminder to send your congratulations, corrections and questions to editor@innovateli.com. We love hearing from you. It’s Nov. 15 out there: On which we remember late greats including German-British Astronomer William Herschel (born 1738, discovered Uranus and a bunch of moons), American artist…


Feinstein, TheraSource target sepsis, with NIH’s help

By GREGORY ZELLER // With a little help from the besieged National Institutes of Health, a pillar of Long Island-based scientific research and one of its shining biotech spinoffs are taking the fight to a modern-medicine scourge responsible for some 500,000 U.S. deaths each year. The Feinstein Institute for Medical Research, the R&D division of the Northwell Health system, and Manhasset-based TheraSource LLC, a circa-2004 biopharma spun out of the Feinstein Institute, announced this week…


Donald Trump, Long Island and the war on science

By GREGORY ZELLER // There’s worry, if not panic, among the scientists at the heart of the Long Island innovation economy. Certainly, none are surprised that President Donald Trump, in his first proposed budget, took square aim at the federal funding that is the lifeblood of the nation’s scientific research programs. This is, after all, a president who calls climate change a hoax, champions coal and selected a former ExxonMobil CEO as his secretary of…


Researchers zoom in on schizophrenia biomarkers

A Feinstein Institute for Medical Research scientist will focus next-level imaging techniques on schizophrenia and other brain disorders, thanks to a hefty federal grant. Research scientist Anil Malhotra – a professor in the Feinstein Institute’s Center for Psychiatric Neuroscience and the Hofstra Northwell School of Medicine’s Department of Molecular Medicine – has been awarded a five-year, $3 million R01 grant from the National Institutes of Health to identify biomarkers specific to schizophrenia and treatment-resistant psychosis. The biomarkers…


NIH pumps $3M into Feinstein autism study

The National Institutes of Health will fund a two-year Feinstein Institute for Medical Research study exploring risk factors behind autism spectrum disorders in newborns. A $3 million NIH grant has been awarded to MDs Betty Diamond and Peter Gregersen, researchers in the Northwell Health System’s Manhasset-based R&D division, specifically to explore the relationship between a mother’s autoimmunity during pregnancy and the risk of ASD in her child. The researchers are following up previous studies in…


Feinstein researchers nab major NIH awards

Two cutting-edge Feinstein Institute for Medical Research projects have been selected for an elite National Institutes of Health funding program. Kevin Tracey, the institute’s president and CEO, and Ping Wang, Feinstein’s chief scientific officer, will continue their groundbreaking research into bioelectronic medicine and sepsis, respectively, with help from the NIH’s Maximizing Investigators’ Research Awards program. Through the NIH’s National Institute of General Medical Sciences – which supports “basic research that increases understanding of biological processes…


Envisagenics lands $225K NIH award

Bioinformatics startup Envisagenics has been awarded a $225,000 award from the National Institutes of Health. The Phase I Small Business Innovation Research Award is the largest capital infusion to date for the LaunchPad Huntington resident, which received $100,000 last month from an Accelerate Long Island seed fund. The firm, a spinoff from Cold Spring Harbor Laboratory, will dedicate the $225,000 to the development of SpliceCore, a cloud-based platform for detecting, quantifying and interpreting NGS data…